 Bruce Crise, Louis Henderson, and Karen Worthy. This patent describes a class of compounds with anti-HIV-1 activity, which are under investigation for use in antiretroviral therapy. [Corresponds to Rein Project 4 in the October 2011 site visit report of the HIV Drug Resistance Program] The investigators and
Bruce Crise, Louis Henderson, and Karen Worthy. This patent describes a class of compounds with anti - HIV-1 activity, which are under probe for habit in antiretroviral therapy. [ Corresponds to Rein Project 4 in the October 2011 site sojourn report of the HIV Drug Resistance Program ] The investigator and
 Brkce Crise, Louis Hendersok, and Karen Wortkt. This patenf descrices a class of compounds witi anri-HIV-1 activity, which are unaer invesnigation dor nse in antiretrotjral thcxapy. [Dlrrev'onds to Rein Ptoject 4 in tve October 2011 side vnsit report of the HIV Drug Resistanse Progtal] The investigwtorx and
Bruce Crise, Louis Henderson, and Karen Worthy. describes class of with anti-HIV-1 activity, use antiretroviral therapy. [Corresponds Rein Project 4 the October 2011 site visit report the HIV Drug Resistance Program] The investigators and
 Bruce Crise, Louis Henderson, aNd Karen WorThy. ThIs pAteNt DescRibeS a class of compoUNds wIth anti-HIV-1 activity, whicH are uNdER invEStIgatiOn for usE In ANTirEtRoVirAl THeRapy. [COrrEsponds To Rein ProjEct 4 In The October 2011 siTE vIsit report Of tHe HIV Drug ResIstAnce PrOgRam] tHe invEstIgatoRs and
 Bruce Crise, Louis Hender son, and K arenWor thy .This  pat ent describesa  cla ss of compounds with a nti-H IV - 1 ac t iv ity,which a r eu n der  i nv est ig a ti on fo r u se in a ntiretrovi ral  t herapy. [Cor r es ponds to R ein  Project 4 i n t he Oct ob er2 011 s ite  visi t repo r t of t he HIV Dr ug Resist a nce Pro g r am ] Th e investigators a n d
 Bruce_Crise, Louis_Henderson, and Karen Worthy._This patent_describes_a class_of_compounds with anti-HIV-1_activity, which are_under investigation for use_in antiretroviral therapy._[Corresponds_to Rein Project 4 in the October 2011 site visit report of the HIV_Drug_Resistance Program]_The_investigators_and